Use of lithium and anticonvulsants and the rate of chronic kidney disease a nationwide population-based study

JAMA Psychiatry

Volumn 72, Issue 12, 2015, Pages 1182-1191

  Kessing, Lars Vedel ^a   Gerds, Thomas Alexander ^a   Feldt Rasmussen, Bo ^a,b   Andersen, Per Kragh ^a   Licht, Rasmus W ^c  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b AALBORG UNIVERSITY HOSPITAL   (Denmark)

^c AALBORG UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; LITHIUM; ANTIDEPRESSANT AGENT; NEUROLEPTIC AGENT;

ARTICLE; BIPOLAR DISORDER; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DANISH CITIZEN; DENMARK; END STAGE RENAL DISEASE; FEMALE; HUMAN; ICD-10; ICD-8; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MANIA; PRESCRIPTION; RANDOMIZED CONTROLLED TRIAL; ADULT; AGED; CHEMICALLY INDUCED; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC;

ADULT; AGED; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; DENMARK; HUMANS; KIDNEY FAILURE, CHRONIC; LITHIUM; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC;

EID: 84948974627     PISSN: 2168622X     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamapsychiatry.2015.1834     Document Type: Article

References (24)

1. Goodwin GM, Geddes JR. Latest maintenance data on lithium in bipolar disorder. Eur Neuropsychopharmacol. 2003; 13 (suppl 2): S51-S55.
2. CoryellW. Maintenance treatment in bipolar disorder: a reassessment of lithium as the first choice. Bipolar Disord. 2009; 11 (suppl 2): 77-83.
3. Geddes JR, Goodwin GM, Rendell J, et al; BALANCE Investigators and Collaborators. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial. Lancet. 2010; 375 (9712): 385-395.
4. Licht RW. Lithium: still a major option in the management of bipolar disorder. CNS Neurosci Ther. 2012; 18 (3): 219-226.
5. Markowitz GS, Radhakrishnan J, Kambham N, Valeri AM, Hines WH, D'Agati VD. Lithium nephrotoxicity: a progressive combined glomerular and tubulointerstitial nephropathy. J AmSoc Nephrol. 2000; 11 (8): 1439-1448.
6. McCann SM, Daly J, Kelly CB. The impact of long-term lithium treatment on renal function in an outpatient population. Ulster Med J. 2008; 77 (2): 102-105.
7. Aiff H, Attman PO, AurellM, Bendz H, Schön S, Svedlund J. End-stage renal disease associated with prophylactic lithium treatment. Eur Neuropsychopharmacol. 2014; 24 (4): 540-544.
8. Close H, Reilly J, Mason JM, et al. Renal failure in lithium-treated bipolar disorder: a retrospective cohort study. PLoS One. 2014; 9 (3): e90169.
9. Shine B, McKnight RF, Leaver L, Geddes JR. Long-term effects of lithium on renal, thyroid, and parathyroid function: a retrospective analysis of laboratory data. Lancet. 2015; 386 (9992): 461-468.
10. Aiff H, Attman PO, AurellM, Bendz H, Schön S, Svedlund J. The impact of modern treatment principles may have eliminated lithium-induced renal failure. J Psychopharmacol. 2014; 28 (2): 151-154.
11. Gitlin M. Lithium and the kidney: an updated review. Drug Saf. 1999; 20 (3): 231-243.
12. Rej S, Shulman K, Herrmann N, et al. Prevalence and correlates of renal disease in older lithium users: a population-based study. Am J Geriatr Psychiatry. 2014; 22 (11): 1075-1082.
13. Malig C. The Civil Registration Systemin Denmark. Bethesda, MD: International Institute for Vital Registration & Statistics; 1996.
14. Danish National Board of Health. Register of Medicinal Product Statistics, 2002. http://sundhedsstyrelsen.dk/. Accessed October 5, 2015.
15. Juel K, Helweg-Larsen K. The Danish registers of causes of death. Dan Med Bull. 1999; 46 (4): 354-357.
16. Andersen TF, Madsen M, Jørgensen J, Mellemkjoer L, Olsen JH. The Danish National Hospital Register: a valuable source of data for modern health sciences. Dan Med Bull. 1999; 46 (3): 263-268.
17. Munk-Jørgensen P, Mortensen PB. The Danish Psychiatric Central Register. Dan Med Bull. 1997; 44 (1): 82-84.
18. Danish Society of Nephrology. Danish National Register on Regular Dialysis and Transplantation. http://www.nephrology.dk. Accessed October 5, 2015.
19. Smith DJ, Martin D, McLean G, Langan J, Guthrie B, Mercer SW. Multimorbidity in bipolar disorder and undertreatment of cardiovascular disease: a cross sectional study. BMC Med. 2013; 11: 263.
20. Cho DH, Park JH, Joo Lee E, et al. Valproic acid increases NO production via the SH-PTP1-CDK5-eNOS-Ser (116) signaling cascade in endothelial cells and mice. Free Radic Biol Med. 2014; 76: 96-106.
21. Satoh M. Endothelial dysfunction as an underlying pathophysiological condition of chronic kidney disease. Clin Exp Nephrol. 2012; 16 (4): 518-521.
22. Uyanik A, Unal D, Halici Z, et al. Does haloperidol have side effects on histological and stereological structure of the rat kidneys? Ren Fail. 2009; 31 (7): 573-581.
23. Tzeng NS, Hsu YH, Ho SY, et al. Is schizophrenia associated with an increased risk of chronic kidney disease? a nationwide matched-cohort study. BMJ Open. 2015; 5 (1): e006777.
24. Rej S, Elie D, Mucsi I, Looper KJ, Segal M. Chronic kidney disease in lithium-treated older adults: a review of epidemiology, mechanisms, and implications for the treatment of late-life mood disorders. Drugs Aging. 2015; 32 (1): 31-42.